Market Overview

Mobileye Could Collapse By Next Spring, According To Trip Chowdhry

Mobileye Could Collapse By Next Spring, According To Trip Chowdhry

Trip Chowdhry of Global Equities Research has never shied away from explaining his uber-bearish stance on many technology stocks, including Mobileye NV (NYSE: MBLY).

Chowdhry's Advantage 'Not Durable'

Chowdhry reiterated his negative stance on Mobileye on Wednesday and argued that the market continues to move away from the Israel-based provider of advanced driver assistance systems (ADAS) and autonomous driving technologies. Specifically, Autoliv has won a deal with Volvo, NextChip is trying to win a contract with Korean automakers and Germany-based Continental AG is looking to win contracts across Europe and the United States.

"Mobileye's first mover advantage is not durable," the analyst wrote. "Competition from Autoliv, Nextchip and Continental is going to make new design wins difficult for Mobileye."

Chowdhry added that the auto industry has almost decided that Sensor Fusion represents the future of the autonomous driving space and cameras merely play a secondary role.

What Happens In The Spring?

Chowdhry also suggested that in March of next year, Tesla Motors Inc (NASDAQ: TSLA) is likely to show off its vastly improved self-driving and safety features in its Model S and Model X vehicles with its Sensor Suite and new software upgrade.

Accordingly, Mobileye's business is "probably okay" for the next four to six months, but after that, the company could collapse.

Finally, the analyst suggested that a fair value for Mobileye is an enterprise value of between $500 million to $1.0 billion.

Posted-In: autoliv Autonomous Driving NextChipAnalyst Color Travel Analyst Ratings Tech General Best of Benzinga


Related Articles (TSLA + MBLY)

View Comments and Join the Discussion!

Latest Ratings

PNRJefferiesInitiates Coverage On
IPHIBank of AmericaMaintains80.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Sell-Side Reactions To Home Depot's Q3

Mid-Afternoon Market Update: StemCells Climbs On Asset Purchase Agreement; Endologix Shares Drop